Zobrazeno 1 - 2
of 2
pro vyhledávání: '"J. Carl Barrett"'
Autor:
Robert L. Hollis, Alison M. Meynert, Caroline O. Michie, Tzyvia Rye, Michael Churchman, Amelia Hallas-Potts, Ian Croy, W. Glenn McCluggage, Alistair R.W. Williams, Clare Bartos, Yasushi Iida, Aikou Okamoto, Brian Dougherty, J. Carl Barrett, Ruth March, Athena Matakidou, Patricia Roxburgh, Colin A. Semple, D. Paul Harkin, Richard Kennedy, C. Simon Herrington, Charlie Gourley
Publikováno v:
Hollis, R, Meynert, A M, Michie, C O, Rye, T, Churchman, M, Hallas-Potts, A, Croy, I, McCluggage, G W, R Williams, A, Bartos, C, Iida, Y, Okamoto, A, Dougherty, B, Barrett, C J, March, R, Matakidou, A, Roxburgh, P, Semple, C A, D. Harkin, P, Kennedy, R, Herrington, C S & Gourley, C 2022, ' Multiomic characterisation of high grade serous ovarian carcinoma enables high resolution patient stratification ', Clinical Cancer Research . https://doi.org/10.1158/1078-0432.CCR-22-0368
Hollis, R L, Meynert, A M, Michie, C O, Rye, T, Churchman, M, Hallas-Potts, A, Croy, I, McCluggage, W G, Williams, A R W, Bartos, C, Iida, Y, Okamoto, A, Dougherty, B, Barrett, J C, March, R, Matakidou, A, Roxburgh, P, Semple, C A, Harkin, D P, Kennedy, R, Herrington, C S & Gourley, C 2022, ' Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification ', Clinical Cancer Research, vol. 28, no. 16, pp. 3546-3556 . https://doi.org/10.1158/1078-0432.CCR-22-0368
Hollis, R L, Meynert, A M, Michie, C O, Rye, T, Churchman, M, Hallas-Potts, A, Croy, I, McCluggage, W G, Williams, A R W, Bartos, C, Iida, Y, Okamoto, A, Dougherty, B, Barrett, J C, March, R, Matakidou, A, Roxburgh, P, Semple, C A, Harkin, D P, Kennedy, R, Herrington, C S & Gourley, C 2022, ' Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification ', Clinical Cancer Research, vol. 28, no. 16, pp. 3546-3556 . https://doi.org/10.1158/1078-0432.CCR-22-0368
BackgroundHigh grade serous ovarian carcinoma (HGSOC) is the most common type of ovarian cancer; most patients experience disease recurrence which accumulates chemoresistance, leading to treatment failure. Previous investigations have characterised H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b27155f3d0c11f287faceea3137603fd
https://doi.org/10.1101/2022.01.07.22268840
https://doi.org/10.1101/2022.01.07.22268840
Autor:
Jerzy Jurka, Greg Solomon, Vladimir N. Noskov, Vladimir Larionov, John Otstot, Natalay Kouprina, William B. Isaacs, Joanna Schleutker, J. Carl Barrett, John D. Carpten, Jeffrey M. Trent, Adam Pavlicek
Publikováno v:
Genome Research. 15:1477-1486
Genetic linkage studies indicate that germline variations in a gene or genes on chromosome Xq27–28 are implicated in prostate carcinogenesis. The linkage peak of prostate cancer overlies a region of ∼750 kb containing five SPANX genes (SPANX-A1,